Microglia facilitate repair of demyelinated lesions via post-squalene sterol synthesis

Stefan A Berghoff1, Lena Spieth1, Ting Sun1,2

  • 1Department of Neurogenetics, Max Planck Institute of Experimental Medicine, Göttingen, Germany.

Nature Neuroscience
|December 22, 2020
PubMed

Insights

Microglia/macrophages synthesize desmosterol, a cholesterol precursor, to resolve inflammation and promote myelin repair in multiple sclerosis (MS). This finding suggests new therapeutic strategies for demyelinating diseases.

Area of Science:

  • Neuroscience
  • Immunology
  • Biochemistry

Background:

  • Multiple sclerosis (MS) involves inflamed, demyelinated lesions requiring debris clearance and a shift to an anti-inflammatory state.
  • Oligodendrocytes need increased cholesterol for new myelin synthesis, but the regulation of this process in lesions is unclear.

Purpose of the Study:

  • To investigate the role of cholesterol metabolism and sterol synthesis in the resolution of demyelinated lesions.
  • To determine how microglia/macrophage cholesterol processing impacts oligodendrocyte differentiation and remyelination.

Main Methods:

  • Gene expression profiling
  • Genetic analysis
  • Comprehensive phenotyping of demyelinated lesions
  • Pharmacological manipulation of sterol synthesis

Main Results:

  • Microglia/macrophages phagocytosing myelin debris synthesized desmosterol, not cholesterol.
  • Desmosterol activated liver X receptor (LXR) signaling, reducing inflammation and promoting oligodendrocyte differentiation.
  • LXR target genes facilitated lipid and cholesterol efflux from microglia/macrophages, supporting remyelination.

Conclusions:

  • Microglial/macrophage sterol synthesis is a critical, paradoxical regulator of demyelinated lesion repair.
  • Desmosterol-mediated LXR activation is key to resolving inflammation and enabling remyelination.
  • Targeting sterol synthesis offers a potential therapeutic avenue for promoting myelin repair in MS.